Pharmaceutical Technology-12-02-2009

Headed Up or Down? Pharma?s Position in the Current Economy

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

Ahura's Doug Kahn talks about reducing costs and portable instruments.

Multinational firms and governments around the world are flocking to India for R&D partnerships.

Results from our annual employment survey.

Representatives to the PIC/S provide an example of methodology for implementing ICH Q9.

In this article, the authors evaluated the effects of the granulating binder level, binder type, water amount, and water-droplet size on the MADG process.

Readers can learn about the importance of measuring and controlling water activity in a comprehensive new book.

Particularly in a more connected world, individual contributions can make a difference.

Editors' Picks of Pharmaceutical Science & Technology Innovations

Dumbed-down presentations and poor speaker selections are destroying a valuable industry tool.

With so many healthcare and pharmacy websites, consumers could use the agency's nod of support.

Leading experts share insight on polymorphism and crystallization.

Polymorph screening is a critical step in developing an active pharmaceutical ingredient for a pharmaceutical formulation.

The authors discuss a study that demonstrates the use of polyethylene oxide mixtures to investigate the effect of polymer viscosity on formulation robustness.

Blame it on cafeteria gossip, outdated procedures, and major miscommunication.

Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.

The authors describe the development and organization of the Product Quality Research Institute and highlight some of the important projects conducted by its Working Groups.